Cemat A/S
Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K
Copenhagen, 22 March 2021
ANNOUNCEMENT no 8/2021
Closely related persons transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 22 March 2021.
Name: | Peter Taero Nielsen |
Reason for filing: | Closely related person to Joanna Lucyna Iwanowska-Nielsen, member of the board of directors in the company |
Company name: | Cemat A/S |
Identification code and name: | ISIN DK0010271584 |
Transaction type: | Purchase |
Date: | 18 March 2021 |
Market: | Nasdaq Copenhagen |
Number of traded shares: | 45,764 |
Price: | 0.48 |
Cemat A/S
Jaroslaw Pawel Lipinski
CEO
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Scandinavian Investment Group A/S19.9.2025 20:22:33 CEST | Pressemeddelelse
Resultat aktietilbagekøbsprogram 17-19 september 2025
Kensana Health Inc.19.9.2025 19:29:40 CEST | Press release
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
Digitalist Group Oyj19.9.2025 19:00:31 CEST | Press release
Digitalist Group structures its financing
Leading Edge Materials Corp.19.9.2025 18:00:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2025
Sironax19.9.2025 17:00:00 CEST | Press release
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom